By modulating the brains dopamine reward system, GLP-1 agonists show promise in reducing cravings and compulsive behaviors associated with various substance use disorders, including alcohol, nicotine, and potentially opioids and stimulants [14, 16, 17]
Better blood flow also means increased cell volume, which, along with the mechanical tension created from lifting weights, is also a big thing that gives the green light for muscle adaptation
No large clinical trials have directly studied berberine + GLP-1 co-administration in humans, so robust safety data is limited
The list price of brand-name Ozempic is roughly $935, $1,000 per month without insurance
[DOI] [PubMed] [Google Scholar] 49.Peterson RE, Imperato-McGinley J, Gautier T, Sturla E
doi: 10.1073/pnas.87.9.3343